Martin Gleave and Judy Illes among 125 appointed to the Order of Canada

Martin Gleave, Head and Distinguished Professor, Department of Urologic Sciences and Judy Illes, Division of Neurology, Department of Medicine are among 125 newly appointed members to the Order of Canada. Her Excellency the Right Honourable Julie Payette, Governor General of Canada, announced 125 new appointments to the Order of Canada. The Order of Canada is a Canadian national order, admission into which is the second highest honour for merit in the system of orders, decorations, and medals of Canada. The Order of Canada recognizes people in all sectors of Canadian society, representing the arts, sciences, sports, philanthropic and business communities.

Martin Gleave

Dr. Martin Gleave is part of a $10M Dream Team project, a multi-centre “dream team’’ of scientists embarking on a groundbreaking undertaking into personalized medicine, the goal is to overcome therapeutic resistance in the disease and revolutionize treatment for patients with advanced prostate cancer. Dr. Gleave’s research focuses on the mechanisms involved in the propagation of cancer cells and the development of new treatments for prostate cancer. Dr. Gleave is the recipient of numerous awards, including the NCIC’s prestigious William Rawls Award for contributions to cancer control in Canada, the Society of Urologic Oncology’s Young Investigator Award, Finalist and was appointed a Distinguished University Scholar at the University of British Columbia.

Judy Illes

Dr. Judy Illes is the Canada Research Chair in Neuroethics at the University of British Columbia. She is Director of the National Core for Neuroethics at UBC, and faculty in the Brain Research Centre and the Vancouver Coastal Health Research Institute. Dr. Illes is a co-Founder and Member of the Governing Board of the International Neuroethics Society. As a pioneer and eminent scholar in the field of Neuroethics, she has made ground-making contributions to ethical, social, and policy challenges at the intersection of biomedical ethics and neuroscience, including advances in stem cells, neuroimaging, neuroscience and the law, and the commercialization of health care.